Table 1.
Clinical and demographic data of the two study cohorts and the four representative cases.
| Parameters | Cohort I (A0) | Cohort II (A1) | M3A1 | M3A0 | M0A1 | M0A0 |
|---|---|---|---|---|---|---|
| Nr. of cases | 72 | 53 | - | - | - | - |
| LV aneurysm | no | yes | yes | no | yes | no |
| Age (years) | 60 [54 - 69] | 59 [54 - 68] | 60 | 60 | 49 | 62 |
| Sex (m/w) | 62/10 | 42/11 | m | m | m | m |
| BSA (m2) | 1.98 ± 0.19 | 1.91 ± 0.23 | 2.18 | 2.02 | 1.76 | 2.36 |
| MR (grade) | I [I - II/III] | I [I - II] | III | III | - | - |
| NYHA class | III [III - III] | III [III - III] | III | IV | III | III |
Cohort p-values range from 0.143 to 0.676 and are not considered significant. If a parameter is not normally distributed in either cohort, values are shown as median [interquartile range (IQR)] for both cohorts, whereas values are shown as mean ± standard deviation (SD) otherwise. Normality was proved by the Shapiro-Wilk test. The BSA was calculated according to the Dubois formula (42). LV, left ventricle; BSA: body surface area; MR, mitral regurgitation; NYHA, New York Heart Association.